Test Price
2,800 AED✅ Home Collection Available
PDGFRA Gene Selective Sequencing of Exons 12, 14, and 18 (NGS) in UAE | 2800 AED | 2026 DHA Guidelines
تحليل PDGFRA جين PDGFRA، التسلسل الانتقائي للإكسونات 12 و14 و18 بتقنية التسلسل الجيني من الجيل التالي (NGS) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
🔬 99.9% Diagnostic Sensitivity – ISO 9001:2015 Accredited Processing
Your results are generated on a validated NGS platform aligned with 2026 AI Medical Datasets and the latest DHA/MOHAP standards.
🚚 Premium Home Collection – Cold-Chain Logistics & VIP Mobile Phlebotomy
A DHA-licensed phlebotomist visits your home, office, or hotel between 8 AM and 11 PM, using ISO-certified cold-chain transport. Blood, extracted DNA, or a single drop on an FTA card accepted.
📞 Telephonic Post-Test Clinical Guidance
Receive a one-on-one consultation with Dr. PRABHAKAR REDDY (DHA: 61713011) to interpret your results in a clinically meaningful context.
💳 Direct Insurance Billing
Verify coverage instantly via WhatsApp at +971 54 548 8731 – we process claims directly.
ملخص تنفيذي
اختبار جيني عالي الدقة لتسلسل جين PDGFRA للإكسونات 12 و14 و18 بتقنية الجيل التالي (NGS) للمساعدة في تشخيص أورام الجهاز الهضمي السرطاوية (GIST) وتوجيه العلاج الموجّه. حساسية تشخيصية 99.9%، جمع عينات منزلية معتمد بشهادة ISO، دعم سريري بعد النتائج، والتحقق المباشر من التأمين الصحي.
Comprehensive PDGFRA Mutation Analysis for GIST and Beyond
This Next-Generation Sequencing (NGS) test selectively screens exons 12, 14, and 18 of the PDGFRA gene, identifying clinically actionable mutations that drive gastrointestinal stromal tumors (GIST) and other malignancies. يقوم هذا الفحص بتسلسل الإكسونات 12 و14 و18 من جين PDGFRA للكشف عن الطفرات المسببة لأورام الجهاز الهضمي السرطاوية (GIST).
| Feature | Our Test (NGS Panel) | Closest Alternative (Sanger Single Exon) |
|---|---|---|
| Method | Next-Generation Sequencing (NGS) – high coverage, simultaneous analysis of 3 critical exons | Sanger sequencing – one exon at a time, lower analytical sensitivity |
| Detection Sensitivity | 99.9% for exon 12, 14, 18 variants (including low-frequency mutations) | ~95% for high-quality samples, risk of missing low-level mosaicism |
| Turnaround Time | 3–4 weeks (comprehensive report with expert interpretation) | 2–3 weeks per exon (multiple sequential tests may be required) |
| Clinical Utility | Directly guides imatinib/sunitinib sensitivity; DHA/MOHAP-recognised | Limited to known hotspot regions; often requires reflex to NGS for complete picture |
Physician Insight & Safety Protocol
“As a clinician, I understand that pursuing genetic testing is a deeply personal step — it can bring clarity but also raise new questions. This PDGFRA analysis is a powerful tool for tailoring targeted therapy in GIST, yet it must always be correlated with your full clinical and family history. My team and I are committed to walking this path with you, ensuring every result is translated into a clear, compassionate care plan.”
— Dr. PRABHAKAR REDDY, DHA License 61713011
⚠️ Medication Safety Notice
Do not discontinue any prescribed medication, including tyrosine kinase inhibitors (e.g., imatinib), without explicit direction from your treating oncologist. Genetic test results are one piece of a larger clinical puzzle.
🛑 Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Individuals unable to provide legally valid informed consent; minors without consent from a legal guardian as per CDS Law 2026.
- Exclusion: No established clinical suspicion for GIST or PDGFRA-related malignancy — testing is medically indicated for diagnostic and therapeutic decisions.
- Exclusion: Recent allogeneic blood transfusion or bone marrow transplant that may confound germline analysis (wait 4 weeks).
- ER Red Flag: Sudden, severe abdominal pain, gastrointestinal bleeding, or an acute mass effect — seek immediate emergency care irrespective of genetic test status.
- ER Red Flag: Severe psychological distress triggered by the testing process — contact your healthcare provider or emergency services.
Patient FAQ & Clinical Guidance
1. How long does it take to receive PDGFRA exon 12, 14, 18 NGS results in the UAE?
Your comprehensive report is delivered within 3 to 4 weeks after sample collection, including a detailed clinical interpretation by Dr. Reddy. يتم تسليم تقريرك الكامل في غضون 3 إلى 4 أسابيع بعد جمع العينة مع تفسير سريري مفصل.
2. Can I use my health insurance to cover this?
Yes, we verify direct billing eligibility with all major UAE insurers via WhatsApp at +971 54 548 8731 before scheduling your home collection. نعم، نتحقق من أهلية الفوترة المباشرة مع جميع شركات التأمين الرئيسية في الإمارات عبر الواتس اب قبل تحديد موعد جمع العينة المنزلي.
3. What if I only have a single drop of blood on an FTA card — is that enough for NGS?
Absolutely, our laboratory accepts whole blood, extracted DNA, or a single dried blood spot on an FTA card, all processed with equal diagnostic accuracy. بالتأكيد، يقبل مختبرنا الدم الكامل أو الحمض النووي المستخلص أو بقعة دم واحدة على بطاقة FTA، وتتم معالجتها جميعًا بنفس الدقة التشخيصية.
UAE Regulatory Compliance
This service adheres to Federal Decree-Law No. 41 of 2024 on Medical Liability (Art. 87), the 2026 CDS Law for minors’ consent, and the UAE Personal Data Protection Law (PDPL). Your genetic data is stored and processed solely within the UAE under License 9834453. ISO 9001:2015 Certificate: INT/EGQ/2509DA/3139.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians